Correlation Between Q2 Metals and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Q2 Metals and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Q2 Metals and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Q2 Metals Corp and Cannara Biotech, you can compare the effects of market volatilities on Q2 Metals and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Q2 Metals with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Q2 Metals and Cannara Biotech.

Diversification Opportunities for Q2 Metals and Cannara Biotech

-0.43

Correlation Coefficient

Q2 Metals  Cannara Biotech

Very good diversification

The 3 months correlation between QTWO and Cannara is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Q2 Metals Corp and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Q2 Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Q2 Metals Corp are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Q2 Metals i.e., Q2 Metals and Cannara Biotech go up and down completely randomly.

Pair Corralation between Q2 Metals and Cannara Biotech

Assuming the 90 days trading horizon Q2 Metals Corp is expected to generate 1.97 times more return on investment than Cannara Biotech. However, Q2 Metals is 1.97 times more volatile than Cannara Biotech. It trades about 0.03 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.01 per unit of risk. If you would invest  104.00  in Q2 Metals Corp on October 3, 2024 and sell it today you would lose (27.00) from holding Q2 Metals Corp or give up 25.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.79%
Values	Daily Returns

Q2 Metals Corp  vs.  Cannara Biotech

Q2 Metals Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Q2 Metals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Cannara Biotech

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Q2 Metals and Cannara Biotech

The main advantage of trading using opposite Q2 Metals and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Q2 Metals position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Q2 Metals Corp and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.